These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9123282)

  • 1. Assessment of the effects of cadaveric donor bone marrow on chimerism in kidney transplant recipients by the polymerase chain reaction-flow technique.
    Garcia-Morales R; Esquenazi V; Zucker K; Gomez CI; Fuller L; Carreno M; Cirocco R; Alamo A; Karatzas T; Burke GW; Ciancio G; Temple D; Fernandez H; Ricordi C; Tzakis A; Miller J
    Transplant Proc; 1997; 29(1-2):1219-21. PubMed ID: 9123282
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Zucker K; Cirocco R; Ciancio G; Burke G; Roth D; Temple D; Rosen A; Fuller L; Esquenazi V; Karatzas T; Ricordi C; Tzakis A; Miller J
    J Clin Invest; 1997 Mar; 99(5):1118-29. PubMed ID: 9062371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No detectable microchimerism in long-term tolerant recipients of living-donor kidneys.
    Garnier JL; Touraine JL; Gebuhrer L
    Transplant Proc; 1997; 29(1-2):1181. PubMed ID: 9123262
    [No Abstract]   [Full Text] [Related]  

  • 4. An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry.
    Garcia-Morales R; Esquenazi V; Zucker K; Gomez CI; Fuller L; Carreno M; Cirocco R; Alamo A; Karatzas T; Burke GW; Ciancio G; Temple D; Fernandez H; Ricordi C; Tzakis A; Miller J
    Transplantation; 1996 Oct; 62(8):1149-60. PubMed ID: 8900317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Cirocco R; Zucker K; Ciancio G; Burke G; Roth D; Temple D; Fuller L; Esquenazi V; Eskind L; Kenyon NS; Ricordi C; Tzakis A; Miller J
    Transplantation; 1998 Apr; 65(7):956-65. PubMed ID: 9565101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of HLA DR typing by polymerase chain reaction amplification with DR beta 1 sequence-specific primers on cadaveric renal allocation.
    Bryan CF; Harrell K; Aeder MI; Luger AM; Nelson PW; Pierce GE; Ross G; Shield CF; Warady BA
    Transplant Proc; 1993 Dec; 25(6):3060-3. PubMed ID: 8266452
    [No Abstract]   [Full Text] [Related]  

  • 7. Microchimerism in renal transplant recipients correlates with better HLA-DRB1 matched status.
    Matsushita K; Sakamoto K; Sakamaki T; Hayashi R; Yamada K; Kashiwabara H; Yokoyama T
    Transplant Proc; 1997 Jun; 29(4):2290-3. PubMed ID: 9193627
    [No Abstract]   [Full Text] [Related]  

  • 8. Perioperative donor bone marrow infusion in cadaver kidney transplant recipients.
    Garcia-Morales RO; Ciancio G; Mathew J; Jin Y; Rosen A; Ricordi C; Burke GW; Blomberg B; Fuller L; Tzakis AG; Esquenazi V; Miller J
    Transplant Proc; 2001; 33(7-8):3840-3. PubMed ID: 11750636
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA-A, B, C, DRB1, DQB1 matching heterogeneity in 'favourably matched' kidney recipients.
    Rees MT; Darke C
    Transpl Immunol; 2003; 12(1):73-8. PubMed ID: 14551034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better clinical outcome in renal transplant recipients with peripheral blood microchimerism.
    Sakamoto K; Arita S; Sakamaki T; Yamada H; Kusume K; Yoshida T; Okazaki Y; Yamada K; Gunji Y; Shimada H; Ochiai T; Kashiwabara H; Yokoyama T
    Transplant Proc; 2000 Nov; 32(7):1793-4. PubMed ID: 11119940
    [No Abstract]   [Full Text] [Related]  

  • 11. Importance of HLA-DRB1 molecular matching between recipient and donor in cadaveric renal transplantation.
    Takahara S; Sada M; Hatori M; Wang JD; Tsuji T; Kokado Y; Kameoka H; Li D; Ichimaru N; Suzuki S; Nishimura K; Fujioka H; Kojima Y; Miki T; Kita Y; Namiki M; Okuyama A
    Transplant Proc; 1996 Jun; 28(3):1255-6. PubMed ID: 8658647
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of beta-pleated sheet DRB1 differences in acute rejection after cadaveric renal transplant.
    Adorno D; Canossi A; Piazza A; Poggi E; Papola F; Di Rocco M; Liberatore G; Del Beato T; Ozzella G; Anaclerio M; Casciani CU
    Transplant Proc; 1999; 31(1-2):730-3. PubMed ID: 10083312
    [No Abstract]   [Full Text] [Related]  

  • 13. Donor bone marrow, chimerism, histocompatibility and renal allograft rejection.
    Ciancio G; Garcia-Morales R; Burke GW; Roth D; Esquenazi V; Tzakis A; Miller J
    Transplant Proc; 1999; 31(1-2):679. PubMed ID: 10083291
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term kidney graft outcome based on HLA-DRB1 matching.
    Nojima M; Ichikawa Y; Ihara H; Ishibashi MO; Ohshima S; Ikoma F
    Transplant Proc; 1994 Aug; 26(4):1884-6. PubMed ID: 7915054
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients.
    Ciancio G; Burke GW; Garcia-Morales R; Suzart K; Rosen A; Ricordi C; Kenyon NS; Mathew JM; Tzakis AG; Esquenazi V; Miller J
    Transplantation; 2002 Aug; 74(4):488-96. PubMed ID: 12352907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of HLA-DRB1 molecular matching based on three-dimensional structure in cadaveric renal transplantation: a trial of new criteria for recipient and donor selection.
    Sada M; Takahara S; Tada M; Hatori M; Wang JD; Okuyama A; Tsuji T
    Transplant Proc; 1997; 29(1-2):1440-2. PubMed ID: 9123371
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of rare HLA-DRB1-DQB1 haplotypes in kidney donors and recipients.
    Scherer S; Mytilineos J; Forssmann U; Dunckley H; Trejaut J; Chapman J; Middleton D; Opelz G
    Transplant Proc; 1995 Feb; 27(1):684-5. PubMed ID: 7879145
    [No Abstract]   [Full Text] [Related]  

  • 18. Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up.
    Rao AS; Fontes P; Iyengar A; Shapiro R; Dodson F; Corry R; Pham S; Jordan M; Zeevi A; Rastellini C; Aitouche A; Egidi F; Gritsch HA; Reyes J; Fung JJ; Starzl TE
    Transplant Proc; 1997; 29(1-2):1184-5. PubMed ID: 9123264
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of solid phase automated sequencing to define HLA disparity between bone marrow donors and recipients.
    Baxter-Lowe LA; Keever C; Dinauer D; Daniels T; Johnson K; Camitta B; Drobyski W; Garbrecht F; Horowitz M; Pietryga D
    Transplant Proc; 1995 Feb; 27(1):1377-8. PubMed ID: 7878917
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of HLA-DR matching at the DNA level in clinical renal transplantation.
    Kobayashi T; Kamura H; Kohara S; Yokoyama I; Orihara A; Tominaga Y; Uchida K; Takagi H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):222-3. PubMed ID: 8438278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.